Spiriva and the FDA

Matthew Mintz: “The FDA release give such little information that your doctor will not likely be able to tell you much more, and may suggest stopping it simply because he or she is too worried about getting sued.”

Related posts:

1. Vytorin spin
2. A different take on ACCORD
3. The FDA is considering lifting restrictions for off-label drug promotion
4. The inhaler switch
5. Zetia: What to tell patients
6. The controversy surrounding asthma and long acting beta agonists
7. Did the Avandia scare harm patients, and is Steven Nissen to blame?

  Follow on Twitter   Subscribe